Intertek : announces the expansion and relocation of its bioanalytical LC-MS facility
March 05, 2015 at 02:01 pm EST
Share
March 06, 2015
Strengthening clinical development support for pharmaceutical clients worldwide
San Diego, United States - Intertek, a leading quality solutions provider to industries worldwide, announced the expansion and relocation of its bioanalytical liquid chromatography- mass spectrometry (LC-MS) facility in El Dorado Hills, California to Intertek's existing center of excellence facility in San Diego.
The relocation to the San Diego facility will be completed by June 2015. The increased laboratory capacity of the San Diego facility, which spans 46,000 square feet of laboratories, offices and sample storage, will benefit customers involved in preclinical and clinical small molecule drug development. This will be coupled with investment in new state-of-the-art mass spectrometers which will be operational at the new San Diego LC-MS facility prior to relocation and so avoid service delivery interruption.
Existing large molecule bioanalysis services from the immunochemistry laboratory in San Diego will be strengthened by expanded capability for bioanalytical LC-MS evaluation of biologic drugs such as proteins, antibody therapeutics or biosimilars as a result of the relocation and investment.
Chetan Parmar, Senior Vice President of Intertek Life Sciences, said "Expanding and consolidating our bioanalytical capacity will strengthen our capability to address the challenges our clients encounter during increasingly complex drug development programs and provide them with the right data for informed decision-making".
Intertek has been providing Good Laboratory Practice (GLP) compliant bioanalytical services to global pharmaceutical clients supporting their preclinical and clinical studies for over 20 years and the combined bioanalytical LC-MS/immunochemistry facility will be a key part of Intertek's network of state-of-the art GLP-compliant laboratories.
About Intertek
Intertek is a leading quality solutions provider to industries worldwide. From auditing and inspection, to testing, training, advisory, quality assurance and certification, Intertek adds value for its customers by helping improve the quality and safety of their products, assets and processes. With a network of more than 1,000 laboratories and offices and over 36,000 people in more than 100 countries, Intertek supports companies' success in the global marketplace, by helping customers to meet end users' expectations for safety, sustainability, performance, integrity and desirability in virtually any market worldwide.www.intertek.com
Intertek Group plc is one of the world's leading groups specializing in analysis, control and certification of products and systems. Net sales break down by activity as follows:
- control and certification services for consumer goods (63.4%): including food, pharmaceuticals, textiles, beauty products, consumer electronics, toys, shoes, home appliances, cars. Also, the group is developing an activity to monitor the certification of international standards;
- monitoring and assessment of petroleum and agricultural products (19.9%). Besides, Intertek Group plc offers inspection services to government system and regulators to support commercial activities, contributing to the movement of goods across borders;
- development of quality assurance solutions (16.7%): for the supply chain of oil, gas, nuclear and mining industries.
At the end of 2022, the group operated more than 1,000 inspection offices and laboratories in the world.
Net sales are distributed geographically as follows: the United Kingdom (6.4%), the United States (30%), China and Hong Kong (18.5%), Australia (5.5) and other (39.6%).